The Generational Inversion in Employer Health Costs That Most CFOs Aren’t Seeing

If you run a company and offer health benefits, you have a hidden cost problem. And there is a strong chance you are attributing it to entirely the wrong cause.

Across large employer populations, a consistent pattern is emerging. Employees managing a chronic condition such as diabetes, hypertension, heart disease or asthma — and who also have a mental health diagnosis — cost meaningfully more to treat for their physical illness than those with the same condition but no mental health diagnosis.

Importantly, that difference persists even when isolating the cost of the physical condition itself, excluding spending on therapy or psychiatric medication. What remains is the excess cost of managing a physical disease when a mental health condition is present but not effectively addressed.

Most employers struggle to see this clearly. They experience rising chronic disease costs and respond the way they always have by adjusting formularies, renegotiating unit costs, or tightening utilization. Those levers rarely address the underlying driver, so the trend continues upward.

A cost gap that changes by generation

When looking at data across employer claims populations, the cost gap between employees with and without a mental health comorbidity is often significant, averaging roughly 20% higher when a mental health diagnosis is also present.

But that topline figure obscures a much more important insight: the relationship between mental health and chronic disease cost can vary dramatically by generation.

Among Baby Boomers and Gen X employees, the cost differential can be substantial. In these groups, the presence of a mental health condition is associated with significantly higher spending on chronic disease management. These are also the cohorts that make up the majority of the workforce in many mid-size and enterprise organizations, which means they disproportionately drive overall employer health spend.

Among Millennials and Gen Z, however, a pattern will sometimes shift. While younger employees tend to have higher rates of mental health diagnoses, the associated increase in chronic disease costs is far smaller — and in some cases, effectively neutral.

This is the inversion most employers are missing. The cohorts with the highest prevalence of mental health diagnoses are not necessarily the ones driving excess chronic disease costs.

What’s different about younger employees

Claims data alone does not establish causation, but the generational differences align with what we know about how younger populations approach mental health.

For Millennials and Gen Z, behavioral healthcare is more often a routine part of maintaining overall health rather than something sought only in crisis. They are more likely to engage earlier, seek care proactively, and continue treatment over time. A diagnosis is more likely to represent active management, not a late-stage recognition of a problem that has already compounded.

That distinction matters. When mental health conditions are addressed earlier and more consistently, they may be less likely to exacerbate physical illness over time. In contrast, in older populations, mental health conditions are more likely to go unaddressed until they begin to materially affect physical health, adherence, and utilization.

Peer-reviewed research, including studies published in JAMA Internal Medicine, has long shown that untreated mental health comorbidities are associated with higher costs and utilization in chronic disease populations. What has been less explored is how engagement with behavioral health may change that relationship across different generations.

The emerging pattern suggests that it does.

Why employers are missing it

Inside most organizations, responsibility for healthcare costs is fragmented. The CFO is focused on overall medical trend, while the CHRO oversees benefits design, including behavioral health offerings. These functions often operate from separate data and with different objectives.

As a result, the cost impact of mental health rarely shows up as a behavioral health issue. Instead, it appears as rising chronic disease spend, gets attributed to those conditions, and is managed accordingly.

Without a generational lens, the signal is even harder to detect. Workforce-wide averages mask the fact that the cost burden is concentrated in specific populations — particularly older employees — where it may also be most addressable.

What employers should do next

For organizations with workforces that skew toward Gen X and Baby Boomers, this dynamic may represent one of the most significant and least examined drivers of healthcare cost growth.

The implication is straightforward. Improving access to and engagement with mental healthcare in these populations is both a behavioral health strategy and a chronic disease management strategy.

That requires alignment at the leadership level. CFOs and CHROs need to be looking at the same data and asking the same question: how does chronic disease cost differ for employees with and without a mental health comorbidity, and how does that vary across the workforce?

For many organizations, that analysis has never been run. Without it, there is a strong chance that a meaningful share of healthcare cost growth is being misattributed.

A practical starting point is to examine whether existing chronic disease management programs account for mental health comorbidities. Many do not. Integrating behavioral health screening, coordination, or support into those programs can be a direct response to what the data shows — particularly for populations where the cost impact is most pronounced.

The intervention does not have to be entirely new. But it does need to be connected.

Photo: erhui1979, Getty Images

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.